Clinical Trials Directory

Trials / Completed

CompletedNCT00005425

Statistical Analysis of Vlagtwedde-Vlaardingen Data Set

Status
Completed
Phase
Study type
Observational
Enrollment
Sponsor
National Heart, Lung, and Blood Institute (NHLBI) · NIH
Sex
Male
Age
100 Years
Healthy volunteers
Not accepted

Summary

To determine the effects in early adulthood of asthma, increased bronchial responsiveness, markers of allergy and smoking on pulmonary function level and the effects of these same risk factors on subsequent decline in pulmonary function, because these early adult factors presumably profoundly influence the risk for chronic obstructive pulmonary disease.

Detailed description

DESIGN NARRATIVE: The questions studied included whether the above named risk factors reduced the maximally attained level of pulmonary function in early adulthood, foreshortened the postulated stability of level of pulmonary function between age 18 and 35 and/or unfavorably affected subsequent decline in level of pulmonary function. FEV1/h2, VC/h2 and FEV1/IVC were studied, using graphic smooth techniques and regression analyses techniques on both cross-sectional and longitudinal datasets. In addition, the investigators tested the hypothesis stating that early adult symptoms of asthma, increased bronchial responsiveness, markers of allergy influenced who became a smoker, influenced the amount smoked and/or influenced who stopped smoking relatively early in adult life, using logistic regression analyses and survival analyses. The study completion date listed in this record was obtained from the "End Date" entered in the Protocol Registration and Results System (PRS) record.

Conditions

Timeline

Start date
1992-09-01
Completion
1995-02-01
First posted
2000-05-26
Last updated
2016-03-16

Source: ClinicalTrials.gov record NCT00005425. Inclusion in this directory is not an endorsement.